Internal Medicine, Pulmonary Disease · Atlanta, GA
NPI
1477545499
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1365a Clifton Rd NE, 4th Floor
Atlanta, GA, 30322
Phone (404) 778-5734
Groups this clinician bills Medicare through
Medicare paid, 2024
$66K
1,545 services
Medicare patients, 2024
562
Average age 69
Drug cost, 2024
$7.2M
2,556 prescriptions
Company payments, 2025
$0
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Micah R Fisher was code 94375 (pulmonary function testing), 374 times for 253 patients. In total Micah R Fisher billed 1,545 services in 43 codes, and Medicare paid $66K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94375 Pulmonary Function Testing | Office | 374 | 253 | $21.08 | $7,885 |
| 94729 Pulmonary Function Testing | Office | 239 | 230 | $26.84 | $6,415 |
| 94726 Pulmonary Function Testing | Office | 168 | 160 | $26.87 | $4,514 |
| 99213 Office E&M - Established | Office | 165 | 108 | $57.86 | $9,547 |
| 94618 Pulmonary Function Testing | Office | 114 | 97 | $21.24 | $2,421 |
| 99233 Hospital E&M - Subsequent | Facility | 101 | 49 | $87.90 | $8,878 |
| 99214 Office E&M - Established | Office | 53 | 43 | $85.76 | $4,545 |
| 99204 Office E&M - New | Office | 49 | 49 | $119.74 | $5,867 |
| 94060 Pulmonary Function Testing | Office | 46 | 45 | $18.12 | $833 |
| 94375 Pulmonary Function Testing | Facility | 27 | 27 | $10.50 | $284 |
| 94729 Pulmonary Function Testing | Facility | 25 | 25 | $6.48 | $162 |
| 99291 Critical Care E&M | Facility | 22 | 13 | $157.80 | $3,472 |
| 95012 Pulmonary | Office | 21 | 20 | $13.87 | $291 |
| 99222 Hospital E&M - Initial | Facility | 19 | 19 | $99.81 | $1,896 |
| 99223 Hospital E&M - Initial | Facility | 18 | 18 | $139.45 | $2,510 |
By year: 2022 $78K for 1,600 services; 2023 $79K for 1,542 services; 2024 $66K for 1,545 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82805 Clinical Chemistry | 33 | 31 | $77.19 | $2,547 |
| 83050 Blood Count | 32 | 30 | $8.04 | $257 |
| 82375 Clinical Chemistry | 31 | 29 | $12.07 | $374 |
| 36415 Venipuncture Blood Collection | 16 | 15 | $7.88 | $126 |
| 36600 General Laboratory | 12 | 12 | $22.05 | $265 |
Medicare prescription drug claims, 2024
In 2024, the drug Micah R Fisher prescribed most often to Medicare patients was Ambrisentan, with 362 prescriptions and refills. In total Micah R Fisher wrote 2,556 Medicare prescriptions that cost $7.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ambrisentan Generic | 362 | 364 | 37 | $954K |
| Tadalafil Generic | 245 | 266 | 32 | $199K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 163 | 188 | 51 | $4,316 |
| Eliquis Apixaban | 147 | 205 | 32 | $120K |
| Sildenafil Citrate Generic | 134 | 155 | 19 | $22K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 127 | 149 | 17 | $66K |
| Bosentan Generic | 88 | 88 | Under 11 | $253K |
| Adempas Riociguat | 84 | 84 | Under 11 | $1.1M |
| Furosemide Generic | 81 | 168 | 23 | $235 |
| Opsumit Macitentan | 81 | 81 | Under 11 | $1.0M |
| Winrevair Sotatercept-Csrk | 59 | 59 | Under 11 | $830K |
| Potassium Chloride Generic | 53 | 89 | 11 | $1,012 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 49 | 61 | 11 | $38K |
| Symbicort Budesonide/Formoterol Fumarate | 45 | 67 | 11 | $15K |
| Torsemide Generic | 42 | 64 | Under 11 | $418 |
Brand drugs: 1,156 claims; generic drugs: 1,400 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Micah R Fisher $0 (- in general payments such as food, travel and fees) from 3 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.